Operaciones XBiotech Inc. - XBIT CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.05 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
XBiotech Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 4.89 |
| Abrir* | 4.85 |
| Cambio de 1 año* | -6.37% |
| Rango del día* | 4.85 - 5.21 |
| Rango de 52 semanas | 3.00-6.49 |
| Volumen medio (10 días) | 173.32K |
| Volumen medio (3 meses) | 1.63M |
| Capitalización de mercado | 149.76M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 30.44M |
| Ingresos | 3.51M |
| EPS | -1.03 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 1.22 |
| Próxima fecha de resultados | Aug 7, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | 5.09 | 0.34 | 7.16% | 4.75 | 5.24 | 4.73 |
| Jun 1, 2023 | 4.89 | -0.04 | -0.81% | 4.93 | 5.13 | 4.79 |
| May 31, 2023 | 5.04 | -0.24 | -4.55% | 5.28 | 5.28 | 4.98 |
| May 30, 2023 | 5.27 | -0.03 | -0.57% | 5.30 | 5.54 | 5.23 |
| May 26, 2023 | 5.38 | 0.04 | 0.75% | 5.34 | 5.66 | 4.96 |
| May 25, 2023 | 5.36 | 0.18 | 3.47% | 5.18 | 5.75 | 5.10 |
| May 24, 2023 | 5.02 | -0.71 | -12.39% | 5.73 | 5.75 | 5.02 |
| May 23, 2023 | 5.70 | 0.77 | 15.62% | 4.93 | 5.92 | 4.93 |
| May 22, 2023 | 4.99 | 0.11 | 2.25% | 4.88 | 5.10 | 4.67 |
| May 19, 2023 | 4.91 | -0.08 | -1.60% | 4.99 | 5.02 | 4.76 |
| May 18, 2023 | 5.02 | 0.73 | 17.02% | 4.29 | 5.13 | 4.29 |
| May 17, 2023 | 4.43 | 0.53 | 13.59% | 3.90 | 4.71 | 3.90 |
| May 16, 2023 | 3.35 | 0.07 | 2.13% | 3.28 | 3.41 | 3.24 |
| May 15, 2023 | 3.29 | -0.04 | -1.20% | 3.33 | 3.37 | 3.28 |
| May 12, 2023 | 3.33 | 0.00 | 0.00% | 3.33 | 3.39 | 3.32 |
| May 11, 2023 | 3.33 | 0.09 | 2.78% | 3.24 | 3.33 | 3.24 |
| May 10, 2023 | 3.27 | 0.09 | 2.83% | 3.18 | 3.32 | 3.18 |
| May 9, 2023 | 3.22 | -0.01 | -0.31% | 3.23 | 3.25 | 3.18 |
| May 8, 2023 | 3.27 | -0.01 | -0.30% | 3.28 | 3.30 | 3.23 |
| May 5, 2023 | 3.28 | 0.00 | 0.00% | 3.28 | 3.36 | 3.18 |
XBiotech Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Thursday, June 22, 2023 | ||
| Hora (UTC) (UTC) 15:00 | País US
| Evento XBiotech Inc Annual Shareholders Meeting XBiotech Inc Annual Shareholders MeetingForecast -Previous - |
| Friday, June 23, 2023 | ||
| Hora (UTC) (UTC) 15:00 | País US
| Evento XBiotech Inc Annual Shareholders Meeting XBiotech Inc Annual Shareholders MeetingForecast -Previous - |
| Monday, August 7, 2023 | ||
| Hora (UTC) (UTC) 20:00 | País US
| Evento Q2 2023 XBiotech Inc Earnings Release Q2 2023 XBiotech Inc Earnings ReleaseForecast -Previous - |
| Tuesday, November 7, 2023 | ||
| Hora (UTC) (UTC) 21:00 | País US
| Evento Q3 2023 XBiotech Inc Earnings Release Q3 2023 XBiotech Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 4.01 | 18.394 | 43.997 | 0 | 0 |
| Gastos totales de explotación | 38.5 | 43.476 | 62.273 | -718.767 | 20.994 |
| Gastos de venta/general/administración Gastos, total | 6.305 | 9.388 | 18.198 | 7.143 | 5.269 |
| Investigación y desarrollo | 31.544 | 28.268 | 9.527 | 24.09 | 15.725 |
| Ingresos de explotación | -34.49 | -25.082 | -18.276 | 718.767 | -20.994 |
| Ingresos por intereses (gastos), netos No operativos | 1.023 | -0.244 | 5.952 | -0.324 | -0.148 |
| Otros, netos | -0.121 | -0.132 | -0.503 | 0.01 | 0.004 |
| Ingresos netos antes de impuestos | -33.588 | -25.458 | -12.827 | 718.453 | -21.138 |
| Ingresos netos después de impuestos | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Beneficio neto antes de partidas extra. Elementos | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Ingresos netos | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Beneficio neto diluido | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Promedio ponderado de acciones diluidas | 30.4393 | 30.0434 | 30.8235 | 46.3195 | 35.8043 |
| BPA diluido sin partidas extraordinarias | -1.08084 | -0.57963 | -0.36404 | 14.4352 | -0.59038 |
| Dividends per Share - Common Stock Primary Issue | |||||
| BPA normalizado diluido | -1.08084 | -0.57963 | -0.36404 | 3.91043 | -0.59038 |
| Gastos (ingresos) extraordinarios | 0 | 0 | -750 | ||
| Ingresos | 4.01 | 18.394 | 43.997 | ||
| Coste de los ingresos, total | 0.651 | 5.82 | 34.548 | ||
| Beneficio bruto | 3.359 | 12.574 | 9.449 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 0 | 0.3 | 1.68 | 1.53 | 0.5 |
| Ingresos | 0 | 0.3 | 1.68 | 1.53 | 0.5 |
| Coste de los ingresos, total | 0 | 0.016 | 0.215 | 0.207 | 0.213 |
| Beneficio bruto | 0 | 0.284 | 1.465 | 1.323 | 0.287 |
| Gastos totales de explotación | 7.145 | 8.462 | 8.069 | 13.624 | 8.345 |
| Gastos de venta/general/administración Gastos, total | 0.915 | 1.129 | 0.84 | 3.023 | 1.314 |
| Investigación y desarrollo | 6.23 | 7.317 | 7.014 | 10.394 | 6.818 |
| Ingresos de explotación | -7.145 | -8.162 | -6.389 | -12.094 | -7.845 |
| Ingresos por intereses (gastos), netos No operativos | 3.162 | 5.539 | -3.868 | -2.039 | 1.391 |
| Otros, netos | 0.13 | -0.002 | 0 | -0.119 | 0 |
| Ingresos netos antes de impuestos | -3.853 | -2.625 | -10.257 | -14.252 | -6.454 |
| Ingresos netos después de impuestos | -3.816 | -3.203 | -12.658 | -11.644 | -5.395 |
| Beneficio neto antes de partidas extra. Elementos | -3.816 | -3.203 | -12.658 | -11.644 | -5.395 |
| Ingresos netos | -3.816 | -3.203 | -12.658 | -11.644 | -5.395 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -3.816 | -3.203 | -12.658 | -11.644 | -5.395 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -3.816 | -3.203 | -12.658 | -11.644 | -5.395 |
| Beneficio neto diluido | -3.816 | -3.203 | -12.658 | -11.644 | -5.395 |
| Promedio ponderado de acciones diluidas | 30.4393 | 30.4393 | 30.4393 | 30.4393 | 30.0434 |
| BPA diluido sin partidas extraordinarias | -0.12536 | -0.10523 | -0.41584 | -0.38253 | -0.17957 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.12536 | -0.10523 | -0.41584 | -0.38253 | -0.17957 |
| Other Operating Expenses, Total | |||||
| Gastos (ingresos) extraordinarios |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 219.843 | 246.87 | 325.875 | 716.263 | 17.016 |
| Efectivo e inversiones a corto plazo | 217.478 | 236.983 | 237.366 | 714.594 | 15.823 |
| Efectivo y Equivalentes | 157.306 | 236.983 | 237.366 | 714.594 | 15.823 |
| Prepaid Expenses | 0.601 | 0.934 | 0.582 | 1.669 | 1.193 |
| Total Assets | 246.103 | 275.177 | 353.744 | 816.877 | 44.345 |
| Property/Plant/Equipment, Total - Net | 26.26 | 28.307 | 27.336 | 25.171 | 27.329 |
| Property/Plant/Equipment, Total - Gross | 42.755 | 44.039 | 40.447 | 36.9 | 36.695 |
| Accumulated Depreciation, Total | -16.495 | -15.731 | -13.111 | -11.729 | -9.366 |
| Total Current Liabilities | 4.066 | 3.453 | 3.984 | 60.19 | 2.944 |
| Accounts Payable | 2.408 | 2.069 | 2.491 | 2.149 | 1.653 |
| Accrued Expenses | 1.603 | 1.374 | 1.351 | 4.18 | 1.291 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.701 | 5.792 | 5.105 | 61.246 | 2.947 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 1.576 | 1.466 | 1.121 | 1.056 | 0.003 |
| Total Equity | 240.402 | 269.385 | 348.639 | 755.631 | 41.398 |
| Common Stock | 267.325 | 262.263 | 249.805 | 324.808 | 279.353 |
| Retained Earnings (Accumulated Deficit) | -27.749 | 5.151 | 97.568 | 430.929 | -237.7 |
| Other Equity, Total | 0.826 | 1.971 | 1.266 | -0.106 | -0.255 |
| Total Liabilities & Shareholders’ Equity | 246.103 | 275.177 | 353.744 | 816.877 | 44.345 |
| Total Common Shares Outstanding | 30.4393 | 30.4393 | 29.3044 | 41.5196 | 35.8998 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Note Receivable - Long Term | 0 | 75 | |||
| Other Long Term Assets, Total | 0 | 0.533 | 0.443 | ||
| Other Current Liabilities, Total | 0.055 | 0.01 | 0.142 | 53.861 | |
| Total deudores, neto | 1.764 | 8.953 | 85.75 | ||
| Accounts Receivable - Trade, Net | 1.216 | 0 | 4.113 | ||
| Other Current Assets, Total | 0 | 2.177 | |||
| Deferred Income Tax | 0.059 | 0.873 | |||
| Inversiones a corto plazo | 60.172 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 216.284 | 219.843 | 223.427 | 238.764 | 242.98 |
| Efectivo e inversiones a corto plazo | 212.662 | 217.478 | 220.1 | 225.793 | 231.821 |
| Efectivo y Equivalentes | 152.484 | 157.306 | 160.568 | 225.793 | 231.821 |
| Total deudores, neto | 2.919 | 1.764 | 2.706 | 12.426 | 10.527 |
| Accounts Receivable - Trade, Net | 2.371 | 1.216 | 1.53 | 0.5 | |
| Prepaid Expenses | 0.703 | 0.601 | 0.621 | 0.545 | 0.632 |
| Other Current Assets, Total | |||||
| Total Assets | 242.121 | 246.103 | 250.834 | 266.462 | 270.803 |
| Property/Plant/Equipment, Total - Net | 25.837 | 26.26 | 26.635 | 27.276 | 27.823 |
| Other Long Term Assets, Total | 0.772 | 0.422 | 0 | ||
| Total Current Liabilities | 3.618 | 4.066 | 3.578 | 8.235 | 2.891 |
| Accounts Payable | 1.357 | 2.408 | 1.376 | 2.454 | 1.323 |
| Accrued Expenses | 2.206 | 1.603 | 1.988 | 5.588 | 1.568 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.055 | 0.055 | 0.214 | 0.193 | 0 |
| Total Liabilities | 5.216 | 5.701 | 6.025 | 10.667 | 5.243 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 1.598 | 1.576 | 1.575 | 1.559 | 1.479 |
| Total Equity | 236.905 | 240.402 | 244.809 | 255.795 | 265.56 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 268.03 | 267.325 | 266.287 | 265.159 | 263.711 |
| Retained Earnings (Accumulated Deficit) | -31.565 | -27.749 | -24.546 | -11.888 | -0.244 |
| Other Equity, Total | 0.44 | 0.826 | 3.068 | 2.524 | 2.093 |
| Total Liabilities & Shareholders’ Equity | 242.121 | 246.103 | 250.834 | 266.462 | 270.803 |
| Total Common Shares Outstanding | 30.4393 | 30.4393 | 30.4393 | 30.4393 | 30.4393 |
| Deferred Income Tax | 0 | 0.059 | 0.872 | 0.873 | 0.873 |
| Inversiones a corto plazo | 60.178 | 60.172 | 59.532 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -32.9 | -17.414 | -11.221 | 668.629 | -21.138 |
| Efectivo de actividades de explotación | -14.824 | 69.445 | -65.149 | -18.27 | -16.537 |
| Efectivo de actividades de explotación | 2.614 | 2.648 | 2.238 | 2.361 | 2.433 |
| Partidas no monetarias | 6.646 | 6.64 | 10.404 | -747.086 | 1.66 |
| Cambios en el capital circulante | 8.816 | 77.038 | -66.48 | 57.826 | 0.508 |
| Efectivo de actividades de inversión | -63.892 | -3.525 | -3.727 | 674.796 | -0.122 |
| Gastos de capital | -0.585 | -3.525 | -3.727 | -0.204 | -0.122 |
| Efectivo procedente de actividades de financiación | 0 | -67.008 | -409.724 | 42.096 | 0.201 |
| Elementos de flujo de caja de financiación | 0 | 0 | 0.302 | ||
| Emisión (retiro) de acciones, neto | 0 | 7.995 | -409.724 | 41.794 | 0.201 |
| Efectos del cambio de divisas | -0.961 | 0.705 | 1.372 | 0.149 | 0.513 |
| Variación neta de la tesorería | -79.677 | -0.383 | -477.228 | 698.771 | -15.945 |
| Otras partidas de flujo de caja de inversión, total | -63.307 | 0 | 0 | 675 | |
| Deferred Taxes | 0 | 0.533 | -0.09 | ||
| Cash Taxes Paid | 0 | 54.087 | |||
| Total Cash Dividends Paid | 0 | -75.003 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -3.816 | -32.9 | -29.697 | -17.039 | -5.395 |
| Cash From Operating Activities | -4.808 | -14.824 | -17.527 | -11.5 | -5.123 |
| Cash From Operating Activities | 0.443 | 2.614 | 2.171 | 1.437 | 0.71 |
| Non-Cash Items | -0.833 | 6.646 | 4.024 | 2.896 | 1.448 |
| Changes in Working Capital | -0.543 | 8.816 | 6.748 | 1.629 | -1.886 |
| Cash From Investing Activities | -0.006 | -63.892 | -59.985 | -0.243 | -0.161 |
| Capital Expenditures | -0.006 | -0.585 | -0.453 | -0.243 | -0.161 |
| Cash From Financing Activities | 0 | 0 | 0 | 0 | |
| Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
| Foreign Exchange Effects | -0.008 | -0.961 | 1.097 | 0.553 | 0.122 |
| Net Change in Cash | -4.822 | -79.677 | -76.415 | -11.19 | -5.162 |
| Deferred Taxes | -0.059 | 0 | -0.773 | -0.423 | 0 |
| Financing Cash Flow Items | |||||
| Total Cash Dividends Paid | 0 | 0 | |||
| Other Investing Cash Flow Items, Total | -63.307 | -59.532 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Gut (Thomas) | Individual Investor | 12.8588 | 3914111 | 0 | 2022-12-31 | |
| Simard (John) | Individual Investor | 12.56 | 3823166 | -100000 | 2023-03-15 | LOW |
| McKenzie (Thorpe W) | Individual Investor | 8.8825 | 2703759 | -332500 | 2023-03-15 | LOW |
| Lombard International Assurance, S.A. | Insurance Company | 3.6606 | 1114256 | -988853 | 2022-05-19 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8071 | 854469 | 0 | 2023-03-31 | LOW |
| Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 0.8058 | 245270 | 0 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.8057 | 245246 | 995 | 2023-03-31 | LOW |
| Waldin (Jan-Paul) | Individual Investor | 0.6578 | 200243 | 0 | 2023-03-15 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5095 | 155083 | 0 | 2023-03-31 | LOW |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.3756 | 114340 | -9060 | 2023-03-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 0.3378 | 102837 | -22799 | 2023-03-31 | HIGH |
| Morgan Stanley & Co. LLC | Research Firm | 0.2831 | 86184 | 227 | 2023-03-31 | MED |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.2468 | 75126 | -7272 | 2023-03-31 | LOW |
| Connor, Clark & Lunn Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.1903 | 57916 | -7110 | 2023-03-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1882 | 57295 | 0 | 2023-03-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.1725 | 52495 | -48973 | 2023-03-31 | HIGH |
| Numeric Investors LLC | Investment Advisor/Hedge Fund | 0.1649 | 50202 | 1189 | 2023-03-31 | MED |
| Newton Investment Management North America, LLC | Investment Advisor | 0.1527 | 46495 | 0 | 2023-03-31 | MED |
| Millennium Management LLC | Hedge Fund | 0.15 | 45651 | -6593 | 2023-03-31 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1348 | 41031 | 3314 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
XBiotech Inc. Company profile
Sobre XBiotech Inc
XBiotech Inc. es una empresa biofarmacéutica que descubre y desarrolla anticuerpos monoclonales verdaderamente humanos para el tratamiento de diversas enfermedades. La empresa se dedica al desarrollo de tecnologías de fabricación biotecnológica diseñadas para producir terapias de forma flexible. Ha desarrollado una línea de productos candidatos dirigidos a enfermedades inflamatorias e infecciosas. También ha desarrollado una tecnología de fabricación a escala comercial que reduce el tiempo de lanzamiento de nuevos productos candidatos. Se centra en las terapias que bloquean una potente sustancia producida naturalmente por el organismo, conocida como interleucina-1 alfa (IL-1a), que media en la descomposición de los tejidos, la angiogénesis, la formación de coágulos sanguíneos y la inflamación. La IL-1a es una proteína que se encuentra sobre o dentro de las células del cuerpo y está implicada en la respuesta del organismo a las lesiones o traumatismos. Los anticuerpos terapéuticos True Human de la empresa se desarrollan internamente utilizando su plataforma de descubrimiento.
El precio actual de la acción XBiotech Inc. en tiempo real es 5.13 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Tullow Oil PLC, Wallenstam B, Banca Generali SPA, Hamilton Lane, Shoals Technologies Group y Infosys Adr. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Bio Therapeutic Drugs |
5217 Winnebago Lane
AUSTIN
TEXAS 78744
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com